ArticleArchives of endocrinology and metabolism2022

Peptide receptor radionuclide therapy (PRRT) in radioiodine-refractory thyroid cancer: A case report of significant response to lu177 DOTA-TATE treatment.

Saeideh Ataei-Nakhaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.